Retention Rate and Safety of Biosimilar CT-P13 in Rheumatoid Arthritis: Data from the Korean College of Rheumatology Biologics Registry

OBJECTIVE: The aim was to evaluate long-term drug retention, discontinuation, efficacy and safety of CT-P13 and reference infliximab in patients with rheumatoid arthritis (RA) enrolled in the Korean College of Rheumatology Biologics (KOBIO) registry. METHODS: Patients included adults with RA who rec...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Hyoun-Ah, Lee, Eunyoung, Lee, Sun-Kyung, Park, Yong-Beom, Lee, Young Nam, Kang, Hee Jung, Shin, Kichul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2019
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6985057/
https://www.ncbi.nlm.nih.gov/pubmed/31734899
http://dx.doi.org/10.1007/s40259-019-00393-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6985057/
https://www.ncbi.nlm.nih.gov/pubmed/31734899
http://dx.doi.org/10.1007/s40259-019-00393-y

Ejemplares similares